In a new pre-clinical study published today in the journal Breast Cancer Research and Treatment, researchers from the Parise lab show they can exploit cancer’s reliance on a particular protein to help fight triple negative breast cancer. They believe the protein could be a potential new drug target.
University of North Carolina researchers provide evidence for how the genetic code developed in two distinct stages to help primordial chemicals evolve into cells.
The new experimental assay can help scientists find the precise locations of repair of DNA damage caused by UV radiation and common chemotherapies. The invention could lead to better cancer drugs or improvements in the potency of existing ones.
Congratulations to Mrinalini (Minu) for receiving a Predoctoral Fellowship from the National Heart Lung and Blood Institute of NIH.
The Department continues to rank highly for NIH funding among all Biochemistry departments in the US. In 2014, the Department secured 16.4 million in federal funding and ranks 5th.